Citatuzumab bogatox
From Infogalactic: the planetary knowledge core
| Monoclonal antibody | |
|---|---|
| Type | Fab fragment |
| Source | Humanized (from mouse) |
| Target | TACSTD1 |
| Identifiers | |
| CAS Number | 945228-49-9  |
| ATC code | none |
| UNII | 23J303Z5CA |
| Chemical data | |
| Formula | C3455H5371N921O1060S18 |
| Molecular mass | 77.3 kg/mol |
 (what is this?) (verify) |
|
Citatuzumab bogatox (VB6-845) is a monoclonal antibody Fab fragment fused with bouganin, an ribosome inactivating protein from the plant Bougainvillea spectabilis.[1] It has undergone pre-clinical trials for the treatment of ovarian cancer and other solid tumors.[2]
References
- ↑ International Nonproprietary Names for Pharmaceutical Substances (INN), World Health Organization.
- ↑ Viventia Biotech Inc.: VB6-845
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it. |
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |
Categories:
- Chemical articles having calculated molecular weight overwritten
- Drugs that are a monoclonal antibody
- Articles without EBI source
- Chemicals that do not have a ChemSpider ID assigned
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Monoclonal antibodies
- Monoclonal antibody stubs
- Antineoplastic and immunomodulating drug stubs
